Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves MCRI (Medical Carbon Research Institute) mitral heart valve:

This article was originally published in Clinica

Executive Summary

The US FDA has given Medical Carbon Research Institute (MCRI) the go-ahead to market its On-X mitral prosthetic heart valve. The mechanical valve is made from the Austin, Texas firm's On-X pyrolytic carbon and comprises a bileaflet design with features that include: a near natural length; a haemodynamic curved inlet; full opening leaflets and an optimum orifice size, says MCRI. The company gained US approval for an aortic mechanical heart valve last year (see Clinica No 962, p 20).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel